J. Blanchette
Advanced Drug Delivery Reviews · 2004
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from J. Blanchette's perspective
Ordered by how strongly the researchers J. Blanchette trusts endorse each paper. Same corpus, a different order for every researcher.
- Paclitaxel and its formulations. (International journal of pharmaceutics)
- Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. (Journal of Controlled Release)
- Nanoparticles in cancer therapy and diagnosis. (Advanced Drug Delivery Reviews)
- A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. (Journal of Controlled Release)
- Tumor Regression by Targeted Gene Delivery to the Neovasculature (Science)
- Chitosan as a novel nasal delivery system for vaccines. (Advanced Drug Delivery Reviews)
- Chitosan: some pharmaceutical and biological aspects ‐ an update (The Journal of pharmacy and pharmacology)
- Function and interactions of integrins (Cell and Tissue Research)
- Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. (Nucleic Acids Research)
- Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. (Trends in Parasitology)
Their papers
- Nanoparticle and targeted systems for cancer therapy. (2004) — 2,492 citations